Introduction {#s1}
============

CLC transporter proteins are present in intracellular compartments throughout our bodies -- in our hearts, brains, kidneys, livers, muscles, and guts -- where they catalyze coupled exchange of chloride (Cl^--^) for protons (H^+^) ([@bib39]). Their physiological importance is underscored by phenotypes observed in knockout animals, including severe neurodegeneration and osteopetrosis ([@bib93]; [@bib95]; [@bib31]; [@bib45]), and by their links to human disease, including X-linked mental retardation, epileptic seizures, Dent's disease, and osteopetrosis ([@bib58]; [@bib31]; [@bib99]; [@bib33]).

CLC-ec1 is a prokaryotic homolog that has served as a paradigm for the family ([@bib21]; [@bib56]; [@bib20]; [@bib68]; [@bib64]). Its physiological function enables resistance to acidic conditions, such as those found in host stomachs ([@bib37]). Like all CLC proteins, CLC-ec1 is a homodimer in which each subunit contains an independent anion-permeation pathway ([@bib70]; [@bib61]; [@bib67]; [@bib16]). Studies of CLC-ec1 revealed the importance of two key glutamate residues -- 'Glu~ex~' and 'Glu~in~' ([Figure 1A](#fig1){ref-type="fig"}) in the transport mechanism. Glu~ex~ is positioned at the extracellular entryway to the Cl^--^-permeation pathway, where it acts both as a 'gate' for the transport of Cl^--^ and as a participant in the transport of H^+^ ([@bib17]; [@bib4]). Glu~in~ is located towards the intracellular side of the protein and away from the Cl^--^-permeation pathway, where it appears to act as a H^+^ transfer site ([@bib2]; [@bib54]).

![Key glutamate residues in CLC transporters.\
(**A**) CLC-ec1 wild-type structure (PDB 1ots) showing the external and internal glutamate residues (Glu~ex~ and Glu~in~) in the two subunits of the homodimer. Chloride ions are shown as green spheres. Each subunit independently catalyzes Cl^--^/H^+^ exchange. The approximate transport pathways for these ions are indicated with green and blue arrows. The orange box frames the close-up view (shown in panel B) of the Cl^--^-binding sites along with Glu~ex~. (**B**) Glu~ex~ conformations observed in CLC transporters. Three panels showing structures (top panels) and cartoon representations (bottom panels) depicting the three conformations ('middle', 'up', and 'down') adopted by Glu~ex~ in various CLC structures, WT (1ots), E148Q (1otu), and cmCLC (3org). The S~ext~ and S~cen~ anion-binding sites are labeled in the WT cartoon at left. (**C**) QQQ structure reveals a new conformation for Glu~ex~. Structure and cartoon representations as in panel B. (**D**) Overlay of Glu~ex~/Gln~ex~ conformations seen in QQQ (purple), E148Q (blue), WT (grey) and cmCLC (pink). (**E**) Overlays (stereoview) of WT (grey) and QQQ (purple) illustrate changes in positioning of conserved residues near Glu~ex~.](elife-53479-fig1){#fig1}

In CLC transporter crystal structures, Glu~ex~ has been observed in three different positions relative to the Cl^--^-permeation pathway: 'middle', 'up', and 'down'. The 'middle' conformation is observed in the WT CLC-ec1 structure, where Glu~ex~ occupies the extracellular anion-binding site, 'S~ext~' ([@bib16]; [Figure 1B](#fig1){ref-type="fig"}). The 'up' conformation is seen when Glu~ex~ is mutated to Gln, mimicking protonation of Glu~ex~; here, the side chain moves upward and away from the permeation pathway, allowing a Cl^--^ ion to bind at S~ext~ ([@bib17]; [Figure 1B](#fig1){ref-type="fig"}). The 'down' conformation is seen in the eukaryotic cmCLC structure, where Glu~ex~ plunges downwards into the central anion-binding site, 'S~cen~' ([@bib24]; [Figure 1B](#fig1){ref-type="fig"}). The intracellular anion-binding site, 'S~int~', is a low-affinity site ([@bib84]) and is not depicted.

The rotation of the Glu~ex~ side chain is the only conformational change that has been detected crystallographically in the CLC transporters. A central question, therefore, is whether and how other protein conformational changes contribute to the CLC transport mechanism. In previous work, we used a spectroscopic approach to evaluate conformational changes in CLC-ec1, and we found that raising \[H^+^\] (to protonate Glu~ex~) caused conformational change in regions of the protein outside of the permeation pathway, up to \~20 Å away from Glu~ex~ ([@bib18]; [@bib1]). Using a combination of biochemical crosslinking, double electron-electron resonance (DEER) spectroscopy, functional assays, and molecular dynamics (MD) simulations, we concluded that this H^+^-induced conformational state represents an 'outward-facing open' state, an intermediate in the transport cycle that facilitates anion transport to and from the extracellular side ([@bib46]).

Here, to obtain a high-resolution structure of the H^+^-bound conformational state, we crystallized a triple mutant, 'QQQ', in which glutamines replace three glutamates: Glu~ex~, Glu~in~, and E113. E113 is located within hydrogen bonding distance of Glu~in~ and is computationally predicted to be protonated at neutral pH ([@bib23]). In contrast to the single-point mutants of Glu~in~ and Glu~ex~, which reveal either no conformational change (Gln~in~) ([@bib2]) or only a simple side-chain rotation (Gln~ex~) ([@bib17]), the QQQ mutant structure reveals global conformational change, which generates the expected opening of the extracellular permeation pathway. Unexpectedly, this structure additionally reveals new side-chain conformations for both Gln~ex~ and Gln~in~. Based on this new structure, together with MD simulations, DEER spectroscopy, and functional studies, we propose an updated framework for modeling the CLC transport cycle.

Results {#s2}
=======

New conformation of Glu~ex~ {#s2-1}
---------------------------

The QQQ mutant (E148Q/E203Q/E113Q) was crystallized in the lipidic cubic phase, without any antibody Fab fragment. The structure, determined at 2.6 Å resolution ([Table 1](#table1){ref-type="table"}), reveals an unanticipated change in the conformation of the mutated Glu~ex~ residue, Q148 (Gln~ex~). Instead of occupying the 'up' position, as seen in the structure of the E148Q protein ([@bib17]), the sidechain has moved away from the permeation pathway and into the hydrophobic core of the protein, a conformation we designate as 'out' ([Figure 1C,D](#fig1){ref-type="fig"}). This conformation, which has not previously been observed in the CLC transporters, resembles the conformation of Glu~ex~ in the CLC-1 channel structure ([@bib81]). Originally, it was suggested that this 'out' position may be relevant only to CLC channels, due to the steric clashes with conserved residues that the 'out' conformation would generate based on known CLC transporter structures ([@bib81]). However, our new structure reveals that small adjustments in residues 186, 190, 199, and 357 suffice to accommodate Gln~ex~ occupancy in the hydrophobic core ([Figure 1E](#fig1){ref-type="fig"}).

###### Data collection and refinement statistics. Values in parentheses are for highest-resolution shell

                          QQQ
  ----------------------- --------------------------
  **Data collection**     
  Space group             I222
  Cell dimension          
  a, b, c (Å)             80.97, 120.44, 122.57
  α, β, γ (°)             90.0, 90.0, 90.0
  Resolution (Å)          28.64--2.62 (2.73--2.62)
  R~merge~                0.164 (0.817)
  I/ σI                   8.4 (1.6)
  Completeness %          97.5 (83.1)
  Redundancy              7.4 (4.5)
  **Refinement**          
  Resolution (Å)          39.26--2.62 (2.68--2.62)
  Number of reflections   17029
  R~work~/R~free~         0.192/0.262
                          (0.282--0.293)
  Number of atoms         
  Protein                 3252
  Ions                    3
  Water                   55
  B-factors               
  Protein                 64.9
  Ions                    83.9
  Water                   70.2
  r.m.s deviations        
  Bond length (Å)         0.005
  Bond angle (°)          1.329
  Ramachandran favored    96.3
  Ramachandran outliers   0

Opening of the extracellular vestibule {#s2-2}
--------------------------------------

Analysis of the QQQ structure using HOLE, a program for analyzing the dimensions of pathways through molecular structures ([@bib91]), reveals an opening of the extracellular vestibule, increasing accessibility from the extracellular solution to the anion-permeation pathway, in contrast to previously described structures. In the WT protein, two sub-Angstrom bottlenecks occur between S~cen~ and the extracellular side of the protein ([Figure 2A](#fig2){ref-type="fig"}). In the QQQ protein, these bottlenecks are relieved, widening the pathway to roughly the size of a Cl^--^ ion ([Figure 2A](#fig2){ref-type="fig"}, [Video 1](#video1){ref-type="video"}). In contrast, a single point mutation at the Glu~ex~ position (E148Q) relieves only one of the two bottlenecks ([Figure 2A](#fig2){ref-type="fig"}). This observation is consistent with the QQQ structure representing the CLC-ec1 outward-facing open state.

![Helices M-N-O-P move to widen the extracellular vestibule.\
(**A**) Comparison of pore radius profiles of CLC-ec1 with Glu~ex~ in the 'middle' (WT), 'up' (E148Q), and 'out' (QQQ) positions. The pore-radius profile, calculated using HOLE, is aligned with the structure at left (E148Q) to indicate the position of the S~ext~ and S~cen~ anion-binding sites. (**B**) Two views of the CLC-ec1 E148Q structure, with ribbons highlighting helices M-N-O-P (helices located in the extracellular half of the protein) and F (located in the intracellular half). (**C**) Overlay of the CLC-ec1 QQQ structure (purple) with E148Q (blue) following structural alignment using segments of helices B, F, G, and I (residues 35--47, 153--164, 174--190, and 215--223). (**D**) Plot of the differences in Cα positions between WT CLC-ec1 and QQQ (purple) or between WT and E148Q (blue), based on the B-F-G-I structural alignment. The black bars indicate 17 of the 18 alpha helices. (Density for Helix A is absent in QQQ.) The locations of Gln~ex~ and Gln~in~ are marked as solid-black circles and squares, respectively. The differences in the H-I and I-J linkers are not shown here but are discussed below and in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}. (**E**) Zoomed-in view of the structural overlay between CLC-ec1 QQQ and E148Q, showing changes in the positions of conserved residues F190, F199, and F357 and the corresponding electron density from the QQQ structure determination. Additional views are shown in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**F, G**) Illustration of interatom distances at the extracellular bottleneck that are increased in QQQ (**G**) compared to E148Q (**F**). Comparisons of Cl^--^ coordination distances are shown in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}.](elife-53479-fig2){#fig2}

###### QQQ structure.

Gln~ex~ and inner-gate residues are shown as sticks. The pore profile detected using Caver with probe radius 1.2 Å, starting from S~cen~, is indicated in yellow.

The extracellular bottleneck to anion permeation is formed in part by Helix N, which together with Helix F forms the anion-selectivity filter ([@bib16]). Previously, we proposed that generation of the outward-facing open state involves movement of Helix N in conjunction with its neighbor Helix P (at the dimer interface) to widen this bottleneck ([@bib46]). In addition, Helix N motions have been inferred from experiments on the mammalian antiporter CLC-4 ([@bib78]) and from the gating effects of Helix-N disease causing mutations in CLC-1 ([@bib104]; [@bib107]; [@bib86]; [@bib98]). Disease-causing mutations in Helix N are also found in CLC-Kb, CLC-5, and CLC-7 ([@bib49]; [@bib51]; [@bib60]). Structural alignment of the QQQ mutant with either E148Q ([Figure 2B--D](#fig2){ref-type="fig"}) or WT ([Figure 2D](#fig2){ref-type="fig"}) confirms the movement of these helices. These structural changes involve shifts in highly conserved residues near the anion-permeation pathway, including F190 (Helix G), F199 (Helix H), and F357 (Helix N). The side chains of all repositioned residues show good electron density ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Together, these motions widen the extracellular bottleneck ([Figure 2F,G](#fig2){ref-type="fig"}).

The intracellular barrier remains constricted {#s2-3}
---------------------------------------------

Ion channels have uninterrupted permeation pathways that extend from extracellular to intracellular sides of the membrane, facilitating ion movement down (and only down) the ion's electrochemical gradient. In contrast, to facilitate ion pumping, secondary active transporters must have permeation pathways that are alternately exposed to the extracellular or intracellular sides of the membrane, but never to both simultaneously ([@bib38]; [@bib97]; [@bib27]). Since Glu~ex~ in the 'out' position has only been observed in a channel structure (CLC-1) before now, it is prudent to question whether this positioning is compatible with an alternating access mechanism. We therefore examined the QQQ structure along the intracellular aspect of the permeation pathway. In WT CLC-ec1, Cl^--^ permeation to and from the intracellular side is controlled by a constriction formed by conserved residues S107 and Y445, which is thought to act either as a kinetic barrier ([@bib24]; [@bib25]) or as a gate that opens and closes ([@bib3]; [@bib6]). In QQQ, this intracellular constriction is unchanged compared to WT CLC-ec1 and is narrower than that observed in the CLC-1 channel ([Figure 3](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). This maintained intracellular constriction supports QQQ as a viable representative for a transporter intermediate.

![The intracellular constriction remains narrow in QQQ.\
The inter-residue distance between S107 and Y445, conserved residues forming the intracellular constriction, is similar in WT and QQQ (grey and purple in top left panels and overlay below). The equivalent positions in the CLC-1 channel (green, top right panel) are separated by a greater distance, despite the similarity in Glu~ex~ conformation between CLC-1 and QQQ (overlay in bottom right panel).](elife-53479-fig3){#fig3}

Comparison of QQQ and E148Q Cl^--^ binding and transport rates {#s2-4}
--------------------------------------------------------------

The widening of the extracellular Cl^--^ entryway in QQQ is accompanied by subtle changes in the S~ext~ Cl^--^-binding site ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). We therefore hypothesized that Cl^--^ binding to this site might be altered. To test this hypothesis, we used isothermal titration calorimetry (ITC) to compare Cl^--^ binding to QQQ and E148Q (Glu~ex~ to Gln~ex~), which both show the S~ext~ site occupied by Cl^--^ (in contrast to WT CLC-ec1, where the S~ext~ site is occupied by Glu~ex~). We found that QQQ and E148Q bind Cl^--^ with similar affinities (K~d~ = 138 ± 26 µM and 116 ± 6 µM, respectively) ([Figure 4A](#fig4){ref-type="fig"}). Since these measurements do not distinguish between binding to S~cen~ versus binding to S~ext~, we also attempted to distinguish binding at the different sites crystallographically, making use of the anomalous signal obtained from Br^--^ binding, as has been done previously ([@bib59]). However, we have not been successful in our attempts to produce well-diffracting QQQ crystals in the presence of Br^--^. Regardless, while we cannot make specific conclusions about the S~ext~ site, we can conclude that overall binding of Cl^--^ to QQQ and E148Q CLC-ec1 occurs with similar affinity.

![Cl^--^ binding and transport by QQQ and E148Q CLC-ec1.\
(**A**) Cl^--^ binding measured by ITC for QQQ (top panels) and E148Q (bottom panels), at pH 7.5. At left are shown representative data from ITC experiments. At right are shown representative size-exclusion chromatograms of samples before and after the ITC experiment (pre- and post-ITC chromatograms). The dotted line in the pre-ITC chromatogram represents the fraction that was collected for use in the ITC experiment. The sample was run again following the ITC experiment to confirm the sample was stable throughout the experiment. The summary tables show results for 3 experiments performed on 3 separate protein preparations. Averages (± SEM) for E148Q (K~d~ = 116 ± 6 µM) and QQQ (K~d~, = 138 ± 26 µM) are not statistically different (p = 0.19). (**B**) Cartoon depiction of the Cl^--^ flux assay. The Glu~ex~ mutants E148Q and QQQ catalyze downhill transport of Cl^--^. Bulk movement of Cl^--^ is initiated by the addition of valinomycin, and extravesicular Cl^--^ is quantified using a Ag·AgCl electrode. (**C**) At pH 7.5, Cl^--^ transport through the CLC-ec1 QQQ mutant is \~2 fold faster compared to E148Q. The top panel shows representative primary data from the flux assay. The bar graph shows summary data, ± SEM, with n = 12 for each mutant (open circles, samples from 3 independent protein preparations). (**D**) At pH 4.5, favoring protonation of glutamate residues, Cl^--^ transport through E148Q increases by 2-fold, to within 20% the Cl^--^-transport rates by QQQ. The bar graph shows summary data, ± SEM, with n = 12 for each mutant (open circles, samples from 3 independent preparations).\
Figure 4---source data 1.Contains the source data for the transport rates shown in [Figure 4C,D](#fig4){ref-type="fig"}.](elife-53479-fig4){#fig4}

The widening of the extracellular Cl^--^ entryway in QQQ ([Figure 2](#fig2){ref-type="fig"}) predicts that Cl^--^ transport through QQQ will be faster than through E148Q, if extracellular gate-opening is a rate-limiting step. On the other hand, if Cl^--^ transport through E148Q and QQQ have the same rate-limiting step, then Cl^--^ transport rates, like Cl^--^ binding affinities, should be similar. Experimental measurements revealed that QQQ Cl^--^ transport rates are \~2 fold faster than E148Q transport rates at pH 7.5, the pH at which the binding studies were performed ([Figure 4B,C](#fig4){ref-type="fig"}; [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}), indicating that the two mutants have different rate-limiting steps. If this difference in transport rates is due to the wider extracellular Cl^--^ entryway in QQQ compared to E148Q, then lowering the pH -- to allow E148Q to adopt the QQQ-like (outward-facing open) conformation -- should increase the Cl^--^ transport rate. Consistent with this prediction, transport rates of the E148Q mutant increase by 2-fold at pH 4.5 ([Figure 4D](#fig4){ref-type="fig"}; [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}). These results support the conclusion that E148Q CLC-ec1 (and by extension WT CLC-ec1) undergoes an opening of the extracellular vestibule at low pH. We note that the relatively slow Cl^--^ transport by both E148Q and QQQ compared to WT CLC-ec1 (\~300 s^−1^ versus 2200 s^−1^) is not surprising, given that these Glu~ex~ mutants lack a negatively charged carboxylate to compete Cl^--^ out of the permeation pathway.

Overall conformational change in QQQ {#s2-5}
------------------------------------

To evaluate overall conformational changes in the QQQ structure, we generated difference distance matrices, which provide comparisons that are independent of the structural alignment method ([@bib75]). Overall, comparison of QQQ to WT CLC-ec1 using the difference distance matrices confirms a hot spot of conformational change at Helices K-N (as illustrated in [Figure 2](#fig2){ref-type="fig"}) and highlights additional changes at G, H, I, and Q ([Figure 5A](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}; [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). In contrast, comparison of single-Glu mutant structures to WT reveals only minor (≤0.8 Å) changes ([Figure 5B](#fig5){ref-type="fig"}).

![Cα difference distances matrices.\
Color-blind friendly versions of these plots are shown in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. Difference distance matrix comparing WT CLC-ec1 (1ots) to QQQ reveals intramolecular rearrangements throughout the protein. Differences are between Cα residues on helices; differences in linker regions are discussed in [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}. (**B**) Comparison of WT to E148Q (1otu) or E203Q (2fec) reveals only minor (≤0.8 Å) changes. (**C**) Illustration of inverted topology repeat domains in CLC-ec1. Repeat 1 (Helices B-I, pink) is arranged pseudosymmetrically with Repeat 2 (teal). Helix R (grey) is not part of the repeat domains. Helix A, the N-terminal cytoplasmic helix, is also not part of the repeats; it is not resolved in the QQQ structure and not shown here. (**D**) Changes occur both within and between the inverted topology repeat domains. Matrices are the same as in panel A, laid out to focus on comparing changes within each Repeat domain (left and middle panels) or between the Repeat domains (right panel). Helices G-I (Repeat 1) and J-N (Repeat 2) move substantially relative to one another, while the equivalent sets (O-Q in repeat 2 and B-F in repeat 1) undergo more modest relative changes.\
Figure 5---source data 1.Excel spreadsheet of difference distance matrices shown in [Figure 5](#fig5){ref-type="fig"}.\
Figure 5---source data 2.Summary of RMSD values between inverted Repeat domains in WT and QQQ.](elife-53479-fig5){#fig5}

CLCs, like many secondary active transporters, are comprised of pairs of inverted structural repeats ([@bib14]; [@bib28]). These repeats are homologous domains that are inserted with inverted orientation into the membrane, related to one another by an axis of pseudosymmetry along the membrane plane ([Figure 5C](#fig5){ref-type="fig"}). Conformational exchange of the repeats, with the first repeat adopting the conformation of the second and vice versa, has been shown in other transporters to convert the overall protein structure from outward- to inward-facing, thus facilitating the alternating access mechanism required to achieve secondary active transport ([@bib26]; [@bib12]; [@bib29]; [@bib79]; [@bib87]). Since all previous CLC transporter structures appear 'occluded' (neither inward- nor outward-facing), it is uncertain a priori whether conformational swap will occur upon transition to the outward-facing state in the CLCs. Within each repeat of the QQQ structure, significant changes occur compared to the equivalent repeat in WT CLC-ec1, particularly in Helices H and Q ([Figure 5D](#fig5){ref-type="fig"}). However, the repeats have not interconverted ([Figure 5---source data 2](#fig5sdata2){ref-type="supplementary-material"}). In addition to the changes within each repeat domain, there are substantial changes between the two repeats (relative to one another), most strikingly between Helices G-I of Repeat 1 and Helices J-N of Repeat 2 ([Figure 5D](#fig5){ref-type="fig"}).

Within Repeat 2, the major change occurs at Helices O-Q. This region is of mechanistic interest because a cross-link between residue 399 on Helix O and 432 on Helix Q is known to inhibit transport through coupling to the inner gate ([@bib5]). Interestingly, although we find that Helices O and Q move with respect to the rest of Repeat 2, residues 399 and 432 do not change position with respect to one another and do not couple to movement at the inner gate ([Figure 5---figure supplement 3A--D](#fig5s3){ref-type="fig"}). Thus, our data suggest that the Helix-O motions involved in transition to the outward-facing state are distinct from those postulated to facilitate inner-gate opening. While the mechanistic details linking Helix O-Q movements between outward- and inward-facing states are currently unknown, it is of interest to note that many disease-causing mutations occur in this segment, in both CLC channels ([@bib90]; [@bib86]; [@bib7]) and transporters ([@bib60]; [@bib99]). In Helix O, for example, mutation of a highly conserved glycine residue occurring mid-helix can cause Dent's disease (CLC-5, [@bib92]) or Bartter syndrome (CLC -Kb, [@bib55]). In WT CLC-ec1, the helix is kinked at this glycine; in QQQ, the helix is straight ([Figure 5---figure supplement 3E,F](#fig5s3){ref-type="fig"}).

Within Repeat 1, the major change occurs at Helices G-I. This segment also changes position relative to Repeat 2 ([Figure 5D](#fig5){ref-type="fig"}). Helix H is of mechanistic interest because it contains the Glu~in~ residue that is thought to transfer H^+^ from the intracellular solution to Glu~ex~ ([@bib2]; [@bib3]) and because Helix H is one of the most highly conserved regions of the protein ([@bib16]). The movement of Helices G-I relative to Repeat two is illustrated with structural overlays in [Figure 6A,B](#fig6){ref-type="fig"}. This outward movement provides space for Gln~ex~ to move to the 'out' position ([Figure 6B](#fig6){ref-type="fig"}). The movement of Helices G-I relative to other helices in Repeat one is illustrated in [Figure 6C,D](#fig6){ref-type="fig"}. This movement releases the interaction between residue 113 (Helix D) and Gln~in~ (Helix H) ([Figure 6E](#fig6){ref-type="fig"}). Strikingly, Gln~in~ moves into the hydrophobic core of the protein, to within 6 Å of Gln~ex~ ([Figure 6F](#fig6){ref-type="fig"}). This change is accompanied by a rearrangement of water molecules in the internal core ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

![Conformational change at Helices G-I and repositioning of Gln~in~ (Helix H).\
(**A**) View of one CLC subunit, highlighting Repeat 1 in pink and Repeat 2 in teal. Helix R (not part of the repeats) is shown in grey. (**B**) Movement of Helices G-I (part of Repeat 1) relative to Helices K, M, N (Repeat 2). The compared helices are shown in ribbon, with QQQ in purple and WT in gray (Helices K, M, N) or yellow (G--I). Other helices (WT) are shown as transparent cylinders. The inset illustrates how the movement of Helix H away from Helix N creates space to avoid steric conflict with Gln~ex~ in the 'out' position. (**C**) Movement of Helices G-I relative to other helices in Repeat 1. The compared helices are shown in ribbon, with QQQ in purple and WT in gray (Helices C-E) or yellow (G--I). Other helices (WT) are shown as transparent cylinders. (**D**) Close-up view showing movement of Helix H (containing Gln~in~) away from Helix D. (**E**) Conformational change at Gln~in~ moves it away from Q113. (**F**) Movement of Gln~in~ to the hydrophobic core of the protein brings it to within 6 Å of Gln~ex~. Electron density for Gln~ex~, Gln~in~, and an intervening water molecule is shown in mesh.](elife-53479-fig6){#fig6}

Validation of QQQ conformational change in WT CLC-ec1 using DEER spectroscopy {#s2-6}
-----------------------------------------------------------------------------

Our working hypothesis is that the QQQ mutant structure mimics the outward-facing open intermediate in the WT CLC transport cycle. When working with a mutant, however, one always wonders whether any conformational change observed is relevant to the WT protein. We therefore used DEER spectroscopy to evaluate conformational change in WT CLC-ec1. DEER spectroscopy is advantageous because it can evaluate conformational change by site-directed spin labeling, without the constraints of crystallization. Accurate distance distributions can be obtained for spin labels separated by \~20--70 Å ([@bib40]; [@bib71]; [@bib94]). Since CLC-ec1 is a homodimer \~100 Å in diameter, a simple labeling strategy with one spin label per subunit can provide a sample with optimally spaced probes for distance-change measurements. For example, the extracellular sides of Helices N and O ([Figure 2B,C](#fig2){ref-type="fig"}) are separated by \~50 and 35 Å respectively from their correlates in the other subunit. To test the hypothesis that these helices move, we generated WT CLC-ec1 (cysteine-less background) with spin labels at positions 373, 374 (Helix N) and 385 (Helix O) and performed DEER measurements under two conditions, pH 7.5 and pH 4.5. The rationale for this experimental strategy is that pH 4.5 will promote protonation of Glu~ex~ and Glu~in~, thus favoring a global conformation comparable to that observed in the QQQ structure ([Figure 7A](#fig7){ref-type="fig"}).

![DEER spectroscopy reveals that the QQQ conformation is similar to WT CLC-ec1 at low pH.\
(**A**) Cartoon depiction of the hypothesis. At pH 7.5, the deprotonated Glu~ex~ and Glu~in~ residues will adopt conformations observed in the WT CLC-ec1 crystal structure, while at pH 4.5 they will adopt conformations observed in the QQQ structure, promoting an overall conformational change that leads to widening of the extracellular vestibule. (**B**) -- (**F**) DEER measurements on spin-labeled WT and QQQ CLC-ec1 (both in a cysteine-less background). WT CLC-ec1 exhibits pH-dependent changes in inter-subunit distance distributions for spin labels positioned on Helix N, O, P, or G. QQQ CLC-ec1 DEER measurements show little to no pH dependence and have distance distributions similar to those observed with WT at low pH. The lower panels illustrate the position of each labeled residue on the protein and the Cα inter-subunit distances observed in WT versus QQQ. pH-dependent changes at D417C were shown previously for WT ([@bib46]). Data for samples with spin labels at residue 373, 385, 417, or 171 were acquired using the standard four-pulse protocol; data for the sample labeled at residue 374 were acquired using the five-pulse protocol ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).](elife-53479-fig7){#fig7}

Consistent with our hypothesis, spin labels on Helices N and O exhibited pH-dependent changes in distance distributions in the direction predicted by the QQQ structure ([Figure 7B--D](#fig7){ref-type="fig"}). To provide a more direct comparison of WT to QQQ, we additionally made measurements on spin-labeled QQQ samples (cysteine-less background). At all three positions, the DEER distance distributions showed little to no pH dependence, and they resembled the distributions observed with WT at pH 4.5 ([Figure 7B--D](#fig7){ref-type="fig"}). Similar results were obtained for a spin label on Helix P ([Figures 2C](#fig2){ref-type="fig"} and [7E](#fig7){ref-type="fig"}), which had been shown by cross-linking experiments to move during the CLC-ec1 transport cycle ([@bib46]), thus providing further support for the relevance of the conformational changes observed in QQQ. Finally, to test the predicted conformational change at the intracellular side near the H^+^ permeation pathway (Helix G-I movements, [Figure 6C](#fig6){ref-type="fig"}), we examined a spin label on Helix G. (Helix G inter-subunit distances are better suited to DEER measurements than Helix H inter-subunit distances.) Once again, the WT protein showed a pH-dependent shift in the direction predicted by the QQQ structure, and the QQQ protein showed distance distributions resembling those of WT at pH 4.5 ([Figure 7F](#fig7){ref-type="fig"}). Taken together, the DEER distance distributions provide strong support for the conclusion that the QQQ structure represents a WT CLC-ec1 conformation.

Analysis of water connections to Gln~ex~ {#s2-7}
----------------------------------------

Previous computational studies indicated that water wires can transiently bridge the Glu~ex~ and Glu~in~ residues separated by 12.8 Å in the CLC-ec1 WT structure, which may serve as the pathway for H^+^ transfer ([@bib102]; [@bib30]; [@bib42]). The proximity of these residues in the QQQ structure ([Figure 6F](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}) motivated us to re-evaluate this phenomenon. In our previous studies on WT CLC-ec1, extended MD simulations revealed that water spontaneously enters the hydrophobic core of the protein and transiently and repeatedly forms water wires connecting Glu~ex~ and Glu~in~ ([@bib30]; [@bib42]). Analogous simulation of the QQQ mutant revealed a dramatic and unanticipated result: water penetration into the hydrophobic core of the protein is greatly increased, and water pathways directly connect bulk water in the intracellular solution to Gln~ex~, without requiring intermediate connection to Gln~in~ ([Figure 8A--C](#fig8){ref-type="fig"}). These water pathways were observed frequently during our 600-ns simulation ([Figure 8D](#fig8){ref-type="fig"}, [Video 2](#video2){ref-type="video"}, [Figure 8---figure supplement 1---source data 1](#fig8s1sdata1){ref-type="supplementary-material"}); in contrast, such water pathways were not observed in our previous 400-ns WT simulations ([@bib30]; [@bib42]). The number of water molecules needed to reach bulk water follows a normal distribution, with chains of 5 or six water molecules predominating ([Figure 8D](#fig8){ref-type="fig"}). In contrast, the majority of water wires connecting Glu~ex~ to Glu~in~ in the WT simulation involved seven or more water molecules ([@bib30]; [@bib42]). Moreover, the occurrence of water pathways in the QQQ simulation (36.5%) is over an order of magnitude greater than the occurrence of water wires between Glu~in~ and Glu~ex~ in the WT simulation (1.3%).

![Water pathways between Gln~ex~ and intracellular bulk.\
(**A**) A simulation snapshot showing a continuous water pathway directly connecting Gln~ex~ to the intracellular bulk water in one of the subunits. (**B**) Zoomed in view of the water pathway. In this example, which represents the most frequently observed water pathway (89% of the water pathways), Gln~in~ has rotated away from the position observed in the QQQ crystal structure to make room for the water pathway. The purple side chains show the residue positions observed in the crystal structure; the orange side chains show the residue positions in a representative simulation snapshot. Conserved residue E202 also rotates from its starting position. (**C**) Overall water occupancy map (density contoured at isovalue 0.35) for the side-chain configuration shown in panel B. (**D**) Water pathways between Gln~ex~ and the intracellular bulk water arise spontaneously throughout the 600-ns simulation. Each vertical line in the panels shows the occurrence of a Gln~ex~/bulk-connecting water pathway at that time point, with the length of the line representing the number of water molecules in the shortest path. The number of water molecules needed to reach the bulk water follows a normal distribution dominated by 5--6 water molecules.](elife-53479-fig8){#fig8}

###### Dynamics of water pathways and the Gln~in~ side chain in the QQQ mutant simulation.

Representative segment of the simulation (250.5--337.5 ns, [Figure 8A](#fig8){ref-type="fig"}) showing the dramatic hydration of the hydrophobic lumen by water penetration from the intracellular bulk. The Gln~ex~ (Q148) side chain is accessible to the intracellular bulk through the continuous water pathways spontaneously and frequently formed during the simulation. The water pathway conformations undergo dynamical changes in response to the side-chain orientations of Gln~in~. Protein helices are shown as orange ribbons. The Cl^--^ ion at the S~cen~ site is shown as a green sphere. Key amino acids in proximity of the water pathways or involved in Cl^--^-coordination are shown. See also [Figure 8](#fig8){ref-type="fig"} and Figure 8 supplements.

The absence of water pathways in the WT simulation is likely due to steric hindrance by Glu~in~, E113, and bulky side chains in the vicinity, which together block direct access of intracellular bulk water toward the protein interior (despite the conformational flexibility of Glu~in ~\[[@bib102]\]). In the QQQ simulation, Gln~in~ can equilibrate among five side-chain conformations (Clusters 1--5), all of which can support water pathways ([Figure 8---figure supplement 1A,B](#fig8s1){ref-type="fig"}). Most of the water pathways (96% of pathways observed) occur when Gln~in~ is rotated away from its starting conformation (Clusters 1--3), allowing water to flow along a pathway near Q113 ([Figure 8---figure supplement 1C,D](#fig8s1){ref-type="fig"}, [Figure 8---figure supplement 1---source data 1](#fig8s1sdata1){ref-type="supplementary-material"}; [Video 3](#video3){ref-type="video"}). In these conformations, the Gln~in~ side chain bends away from Q113 and from the bulky residues F199 and I109, thus allowing intracellular bulk water to enter the protein interior without encountering steric occlusion ([Figure 8---figure supplement 2A](#fig8s2){ref-type="fig"}).

###### The inner water pathway.

Video shows the starting conformation of QQQ, with residues Gln~ex~, Gln~in~, and E113Q shown as sticks. The same residues in the WT structure are then shown for comparison, along with the side-chain conformational changes that occur in the MD simulation to allow formation of water pathways from the intracellular side. The water pathway shown corresponds to Cluster 1 in [Figure 8---figure supplement 1D](#fig8s1){ref-type="fig"}.

The predominant water pathway observed in our simulations is roughly parallel to the Cl^--^ permeation pathway ([Figure 8A](#fig8){ref-type="fig"}). This pathway for water (and hence H^+^) entry into the protein is different from that previously suggested by us and others. Previously, it was proposed that H^+^ access to the interior of the protein occurs via an entry portal located near the interfacial side of the homodimer ([@bib53]; [@bib30]; [@bib42]) rather than on the 'inner' pathway observed here. While we do see some water pathways occurring along the interfacial route, on a pathway that is lined by Gln~in~, these occur only rarely ([Figure 8---figure supplement 1D](#fig8s1){ref-type="fig"}). Importantly, the previous mutagenesis studies supporting the interfacial route are also concordant with the inner water pathway observed here. In the previous studies, mutations that add steric bulk at either E202 ([@bib53]) or the adjacent A404 ([@bib30]) were found to inhibit the H^+^ branch of the CLC-ec1 transport cycle. The observation that all water pathways involve rotation of E202 away from its starting position ([Figure 8B](#fig8){ref-type="fig"}, [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}, [Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}), can explain why bulky mutations at this position would interfere with H^+^ transport.

Proton pumping without a titratable residue at the Glu~in~ position {#s2-8}
-------------------------------------------------------------------

Glu~in~ has long been modeled as a H^+^-transfer site in the CLC Cl^--^/H^+^ mechanism ([@bib2]; [@bib68]; [@bib54]; [@bib5]; [@bib3]; [@bib46]). However, this modeling is contradicted by the observation that several CLC transporter homologs can pump H^+^ with robust stoichiometry in the absence of a titratable residue at the Glu~in~ position ([@bib24]; [@bib83]; [@bib96]). In our analysis of water pathways in the MD simulations, we observed that these pathways are not always lined by the Gln~in~ side chain ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). This finding strongly suggests that while Glu~in~ *facilitates* water pathways, it is not required as a direct H^+^-transfer site. To test this hypothesis experimentally, we tested for Cl^--^-coupled H^+^ pumping in mutants with non-titratable residues at the Glu~in~ position. We designed the experiment with a large Cl^--^ gradient and a small H^+^ gradient, both favoring outward movement of the ions; thus, any H^+^ transport into the vesicles must occur via Cl^--^-driven H^+^ pumping, not leak ([Figure 9A](#fig9){ref-type="fig"}). With an Ala residue at the Glu~in~ position (E203A), we observed clear H^+^ pumping above the background signal; by comparison, in line with conventional modeling, the Glu~ex~ mutant E148Q exhibited H^+^ signals similar to control vesicles ([Figure 9B,C](#fig9){ref-type="fig"}; [Figure 9---source data 1](#fig9sdata1){ref-type="supplementary-material"}). While the coupling stoichiometry of E203A is somewhat degraded compared to the WT protein ([Figure 9D](#fig9){ref-type="fig"}), the thermodynamic fact arising from this experiment is that H^+^ pumping occurs with a non-titratable residue at Glu~in~.

![Proton pumping by CLC-ec1 with neutralized Glu~in~ (E203A).\
(**A**) Cartoon depiction of the H^+^/Cl^--^ flux assay. Extravesicular \[Cl^--^\] and \[H^+^\] are simultaneously measured using Ag·AgCl and pH electrodes, respectively. The experimental setup involves a 2-fold gradient for H^+^, such that any leak will involve movement of H^+^ out of the vesicles, and any H^+^ movement into the liposomes must occur via transport coupled to the Cl^--^ gradient (pumping). (**B**) Representative Cl^--^ and H^+^ traces (upper and lower panels, respectively) for CLC-ec1 mutants with a neutral residue at either Glu~in~ (E203A) or Glu~ex~ (E148Q). (**C**) Summary data showing Cl^--^ and H^+^ transport rates, average ± SEM. For E203A, n = 4 (samples from two independent protein preparations); for E148Q, n = 8 (samples from four reconstitutions done with protein from three preparations). (**D**) Cl^--^/H^+^ stoichiometry for E203A, with WT CLC-ec1 shown for comparison. Stoichiometry is determined from the ratio of the ion transport rates (panel C). WT samples are from experiments done on the same days as the E203A and mutant samples shown in [Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}, with n = 10 (samples from five reconstitutions done with protein from four preparations).\
Figure 9---source data 1.Contains the source data for the transport rates shown in [Figure 9](#fig9){ref-type="fig"} and [Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}.](elife-53479-fig9){#fig9}

In the original pioneering study by Accardi et al., Glu~in~ was identified as a H^+^-transfer site following a mutagenesis scan of titratable residues at the intracellular side of CLC-ec1 ([@bib2]). Of the 10 mutants tested, only the Glu~in~ mutant E203Q completely abolished detectable H^+^ transport. To directly compare to this original study, we evaluated E203Q in our assay. As with E203A, we found that E203Q can pump H^+^; however, its coupling stoichiometry is substantially more degraded (Cl^--^/H^+^\~75, [Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}; [Figure 9---source data 1](#fig9sdata1){ref-type="supplementary-material"}). Therefore, it is not too surprising that H^+^ pumping was not detected in the original study. We also examined double mutants, missing titratable residues at both E203 and its hydrogen-bonding partner E113. When these positions are substituted with two alanines, or with the residues found in the cmCLC homolog (Thr and Lys), H^+^ pumping is retained ([Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}). Thus, the conventional thinking of Glu~in~ as a H^+^-transport site must be re-evaluated.

Discussion {#s3}
==========

In this study, we aspired to determine the high-resolution structure of the CLC 'outward-facing open' conformational state. We approached this problem by using a triple mutant, QQQ, to mimic the conformation in which three key Glu residues are in the protonated state. In principle, it should be possible to obtain a similar structure with WT CLC-ec1 at low pH. Though a crystal structure from a low-pH well-solution was previously reported ([@bib16]), the pH in the protein crystal may have been closer to that of the purification buffer (pH 7.5) if mixing was inefficient. In an attempt to definitively capture the low-pH state of WT CLC-ec1, we purified the protein at pH 4.0 and performed crystallization trials with well-solutions varying in pH from 3.4 to 5.6. Multiple crystallization attempts, including a grid screen search around reported conditions, varying the protein concentration from 10 mg/mL up to 50 mg/mL, were unsuccessful. In contrast, at pH 7.5--9.5 (the pH range typically used to crystallize CLC-ec1 proteins), we and others routinely obtain crystals with 10--20 mg/mL protein ([@bib16]; [@bib53]; [@bib46]). Given the challenges in crystallizing WT CLC-ec1 at low pH, the QQQ triple mutant presents a viable and appealing alternative approach to capture the desired outward-facing conformation.

Our conclusion that the QQQ mutant structure represents such an intermediate in the CLC transport mechanism is supported by several pieces of evidence. First, the WT protein under low-pH conditions (glutamate residues protonated), adopts a conformation different from the high-pH condition and similar to the conformation adopted by the QQQ mutant, as detected by DEER spectroscopy ([Figure 7](#fig7){ref-type="fig"}). Second, the movement of Helix P in the QQQ structure ([Figure 7E](#fig7){ref-type="fig"}) is consistent with the inhibition of Cl^--^/H^+^ transport by Helix P cross-linking ([@bib46]). Third, the measured transport rates in QQQ relative to E148Q match our expectation for faster Cl^--^ transport, which was predicted based on the wider extracellular Cl^--^ entryway in the QQQ structure compared to E148Q ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Fourth, the prediction based on MD simulations on the structure -- that Glu~in~ residue need not be titratable -- was validated experimentally ([Figure 9](#fig9){ref-type="fig"}). Fifth, and perhaps most compellingly, the details observed in this conformational state reconcile a multitude of findings in the literature, as will be discussed below.

Our results demand that the paradigm of Glu~in~ as a H^+^-transfer site be re-evaluated. While E203Q has a severely degraded coupling ratio, it retains the ability to pump H^+^ ([Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}); thus, a titratable site at the Glu~in~ position is not an absolute requirement for H^+^ pumping. Moreover, the more robust coupling observed with E203A ([Figure 9](#fig9){ref-type="fig"}) is near that observed upon mutation of D278 and K131 ([@bib2]), titratable residues located on the opposite side of the Cl^--^ permeation pathway relative to E203 (Glu~in~). Therefore, we conclude that the loss of coupling efficiency upon mutation of E203 (and D278 and K131) is not due to loss of a H^+^-transfer site but rather due to an effect on the efficiency of water-pathway formation or on some other aspect of the transport cycle. This conclusion brings clarity to previous results with Glu~in~ mutants. In a study evaluating transport by 15 mutants with different residues substituted at Glu~in~, it was found that all titratable residues supported well coupled Cl^--^/H^+^ transport, with a pH dependence identical to that of the WT protein even with Lys or His at the Glu~in~ position ([@bib54]). In that study, slow H^+^ transport was observed with neutral substitutions at Glu~in~, but it was uncertain at that time whether this transport was a result of *bona fide* H^+^ pumping or an experimental artifact ([@bib54]). Interpreted in the light of our current results, this previous study also supports a model in which the Glu~in~ residue contributes indirectly to the efficiency of the H^+^ transport step.

Our observation of Glu~ex~ in the 'out' position -- observed previously only in a channel homolog -- was unanticipated. However, in retrospect, it should not have been surprising. Compelling rationale for the close connection between CLC transporter and channel mechanisms was made over a decade ago ([@bib68]), with CLC channels proposed to operate as 'broken' transporters. Moreover, it has been shown that at least some channel homologs retain the ability to transport H^+^ as part of the gating cycle ([@bib57]). Therefore, it should not be surprising that CLC channels and transporters share a similar conformation for the Glu~ex~ H^+^-transfer residue. Indeed, the Accardi and Berneche labs recently came to that conclusion based on predictions and tests of their MD simulations ([@bib52]).

The water pathways we identified connect Gln~ex~ directly to the intracellular bulk water. The majority of these pathways (\>94%) are approximately parallel to the Cl^--^-permeation pathway and lined by residue Q113; a small but non-negligible fraction of pathways occurring along an 'interfacial' pathway, lined by residue E202 ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Previously, it was concluded that the interfacial pathway likely predominates, based on the observation that mutation of E113 (or nearby polar residues) to non-polar residues inhibits H^+^ transport by only 4--7 fold, while mutation of E202 inhibits H^+^ transport up to 500-fold ([@bib53]). These mutagenesis results, however, are also consistent with our MD simulation results, given that E202 conformational dynamics are critical to *both* water pathways ([Figure 8---figure supplement 3](#fig8s3){ref-type="fig"}).

A proposed unifying framework for the CLC transport mechanism {#s3-1}
-------------------------------------------------------------

Based on the information gleaned from our study of the QQQ structural intermediate, we propose an updated framework for understanding 2:1 Cl^--^/H^+^ exchange by CLC transporters. This updated model is inspired by four key findings. First, the outward-facing state has improved accessibility for Cl^--^ to exchange to the extracellular side ([Figure 2](#fig2){ref-type="fig"}). This state had been previously predicted ([@bib46]) but is now seen in molecular detail. Second, the protonated Glu~ex~ can adopt an 'out' conformation, within the hydrophobic core of the protein ([Figure 1D,E](#fig1){ref-type="fig"}). This novel conformation allows us to eliminate a disconcerting step that was part of all previous models: movement of a protonated (neutral) Glu~ex~ -- in competition with Cl^--^ -- into the S~cen~ anion-binding site ([@bib69]; [@bib25]; [@bib5]; [@bib46]). Third, water pathways can connect Gln~ex~ (and presumably Glu~ex~) directly to the intracellular solution ([Figure 8](#fig8){ref-type="fig"}). Finally, H^+^ pumping does not require a titratable residue at Glu~in~ ([Figure 9](#fig9){ref-type="fig"}). Together, these findings allow us to propose a revised framework for the Cl^--^/H^+^ exchange model, which maintains consistency with previous studies and resolves lingering problems.

In our revised model ([Figure 10A](#fig10){ref-type="fig"}), the first three states are similar to those proposed previously ([@bib69]; [@bib25]; [@bib5]; [@bib46]). State A reflects the structure seen in WT CLC-ec1, with Glu~ex~ in the 'middle' conformation, occupying S~ext~, and a Cl^--^ occupying S~cen~. Moving clockwise in the transport cycle, binding of Cl^--^ from the intracellular side displaces Glu~ex~ by a 'knock-on' mechanism ([@bib69]), pushing it to the 'up' position and making it available for protonation from the extracellular side (State B). Protonation generates state C, which reflects the structure seen in E148Q CLC-ec1 where Gln~ex~ mimics the protonated Glu~ex~. This sequence of Cl^--^ binding and protonation is consistent with the experimental finding that Cl^--^ and H^+^ can bind simultaneously to the protein ([@bib85]). Subsequently, a protein conformational change generates an 'outward-facing open' state (D). While this state had previously been postulated ([@bib46]), the QQQ structure presented here provides critical molecular details.

![Proposed new framework for the CLC Cl^--^/H^+^ transport cycle.\
(**A**) Starting from state A, which reflects the structure seen in WT CLC-ec1, a single Cl^--^ is bound, and Glu~ex~ is in the 'middle' position. Glu~in~ and E113 are in a H-bonded configuration, restricting water access to the center of the protein. Moving clockwise, binding of Cl^--^ from the intracellular side displaces Glu~ex~ by a 'knock-on' mechanism ([@bib69]), making it available for protonation from the extracellular side (State B). This protonation step generates state C, which reflects the structure seen in E148Q CLC-ec1, with Glu~ex~ in the 'up' conformation. A subsequent H^+^-induced conformational change generates a state D (captured in the QQQ mutant structure), which has an open extracellular vestibule and new positionings for Glu~ex~ and Glu~in~. Conformational dynamics of Glu~in~ allows water pathways to connect Glu~ex~ directly to the intracellular bulk water, as in state E. From State E, deprotonation of Glu~ex~ promotes its return to the anion pathway, in competition with Cl^--^ (state F). Binding of Cl^--^ from the intracellular side, coordinated with inner-gate opening ([@bib5]) (reflected by the dotted lines) generates the original state A. (**B**) The updated transport model is consistent with Cl^--^/H^+^ exchange seen in transporters that do not have a titratable residue at the Glu~in~ position, such as cmCLC. The upper panel shows a structural overlay of QQQ and cmCLC, highlighting the positions of the Thr and Lys residues occurring at the Glu~in~ and E113 positions respectively. The lower panel is a cartoon depiction of the water pathway.](elife-53479-fig10){#fig10}

State D involves a widening of the extracellular vestibule, which will facilitate Cl^--^ binding from and release to the extracellular side. In the QQQ structure (our approximation of State D), the reorientation of Helix N results in subtle changes in Cl^--^-coordination at the S~ext~ site ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), which suggests that binding at this site may be weakened, though we currently lack direct evidence for this conjecture. Regardless of the affinity at S~ext~, the opening of the extracellular permeation pathway in State D will promote Cl^--^ exchange in both directions, which is essential to achieving reversible transport.

In addition to involving a widening of the extracellular vestibule, state D has the protonated Glu~ex~ in an 'out' conformation and within \~5 Å of Glu~in~ ([Figure 6F](#fig6){ref-type="fig"}). At first glance, this positioning suggested to us that Glu~in~ might be participating in an almost direct hand-off of H^+^ to and from Glu~ex~, through an intervening water molecule. However, MD simulations revealed that Gln~in~ is highly dynamic and most often is rotated away from its starting position, allowing the robust formation of water pathways from the intracellular bulk water directly to Gln~ex~ ([Figure 8](#fig8){ref-type="fig"}) (State E). Once such transfer occurs, the deprotonated Glu~ex~ will be disfavored in the hydrophobic core, and it will compete with Cl^--^ for the S~cen~ anion-binding site, generating State F. Although this conformational state has not been observed crystallographically for CLC-ec1, computational studies found that Glu~ex~ favors the S~cen~ position when there are no Cl^--^ ions bound in the pathway (as in State F), ([@bib85]) and that the 'down' position is in general the preferred orientation for Glu~ex~ ([@bib65]). In addition, a recent structure of an Asp~ex~ CLC-ec1 mutant supports that the carboxylate likes to reach down towards S~cen~, in a 'midlow' position, excluding the presence of Cl^--^ at both S~cen~ and S~ext~ ([@bib80]), as depicted in State F. From this state, binding of Cl^--^ from the intracellular side (coordinated with inner-gate opening \[[@bib5]\]) knocks Glu~ex~ back up to S~ext~, generating the original state A. This transport cycle is fully reversible, allowing efficient transport in both directions, as is observed experimentally ([@bib63]).

Our proposed updated transport model ([Figure 10A](#fig10){ref-type="fig"}), in addition to retaining key features based on previous models ([@bib69]; [@bib25]; [@bib5]; [@bib46]), unifies our picture of both CLC transporter and channel mechanisms. First, it is compatible with transporters that have non-titratable residues at Glu~in~ and E113. Our simulations and experiments ([Figures 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}) lead to the conclusion that these residues play a key role in regulating water pathways rather than in direct hand-off of H^+^. From this perspective, the evolution of non-titratable residues in either ([@bib24]) or both ([@bib83]; [@bib96]) of these positions is perfectly sensible. In addition, previous mutagenesis experiments on CLC-ec1 and on mammalian transporters, which demonstrate a surprising tolerance for mutations at Glu~in~ ([@bib106]; [@bib54]) now make more sense. Strikingly, the structural positioning of T269 in cmCLC, located at the Glu~in~ sequence position, matches the structural positioning of Gln~in~ in the QQQ mutant, such that side-chain dynamics could facilitate comparable water pathways ([Figure 10B](#fig10){ref-type="fig"}).

The second unifying feature of our model is that it attests to Glu~ex~ movements being conserved amongst every known type of CLC: 2:1 Cl^--^/H^+^ exchangers, 1:1 F^--^/H^+^ exchangers, and uncoupled Cl^--^ channels. Previously, an 'out' position for Glu~ex~ had been proposed to be essential to the mechanism of F^--^/H^+^ exchangers ([@bib50]), which allow bacteria to resist fluoride toxicity ([@bib96]). However, such a conformation had not been directly observed, and it was postulated that it may be only relevant to the F^--^/H^+^ branch of the CLC family. Structurally, Glu~ex~ in the 'out' position has previously only been observed in a CLC channel. Thus, this conformation is a unifying feature of CLC channels and transporters. Moreover, this conclusion connotes that all CLC proteins act via a 'windmill' mechanism ([@bib50]), in which the protonated Glu~ex~ favors the core of the protein while the deprotonated Glu~ex~ favors the anion-permeation pathway. Such a mechanism is preferable to previous 'piston'-type mechanisms, with Glu~ex~ moving up and down within the anion-permeation pathway, which required a protonated (neutral) Glu~ex~ to compete with negatively charged Cl^--^ ions.

Elements of the transport cycle require future experiments to elucidate details. Prominently, the nature of the inward-facing conformational state remains uncertain. In our model, we indicated inward-opening with dotted lines ([Figure 10](#fig10){ref-type="fig"}, States F, A, B) to reflect this uncertainty. One proposal is that the inner-gate area remains static and transport works via a kinetic barrier to Cl^--^ movement to and from the intracellular side ([@bib24]). Consistent with this proposal, multiscale kinetic modeling revealed that 2:1 Cl^--^/H^+^ exchange can arise from kinetic coupling alone, without the need for large protein conformational change ([@bib65]). An alternative proposal is that CLCs visit a conformationally distinct inward-open state, based on the finding that transport activity is inhibited by cross-links that restrict motion of Helix O, located adjacent to the inner gate ([@bib5]; [@bib3]). This putative inward-open state appears distinct from the conformational change observed in the QQQ mutant, as the inter-residue distances for the cross-link pairs (399/432 and 399/259) are unchanged in QQQ relative to WT ([Figure 5---figure supplement 3D](#fig5s3){ref-type="fig"}). The details of the kinetic-barrier and conformational-change models, and the need for additional experiments on this aspect of transport, have been clearly and comprehensively discussed ([@bib3]; [@bib39]).

Simulations of the QQQ conformational state with the glutamine residues reverted to the native, protonatable glutamate side chains will be needed for full understanding of how protonation and deprotonation of these residues affect the conformational dynamics of side chains and water pathways. In our current model, we propose that Glu~in~ needs to be in the protonated (neutral) state to adopt the position that allows water pathways. This proposal appears harmonious with the hydrophobic nature of the protein core explored by the Gln~in~ side chain and the fact that other CLC homologs use neutral residues at this position ([@bib24]; [@bib83]; [@bib96]). In addition, the proposal is consistent with MD simulations that show the Glu~ex~/Glu~in~ doubly protonated state is highly populated ([@bib65]) and can favor formation of water pathways under certain conditions ([@bib48]). Nevertheless, simulations with glutamate side chains in the QQQ conformational state, together with explicit evaluation of H^+^ transport ([@bib101]; [@bib15]), are needed to elaborate details of the H^+^-transfer steps. In addition, multiscale modeling can expand the picture to include multiple pathways that are likely to occur ([@bib65]). Recognizing the importance of elaborating these details, the results reported here represent an essential and pivotal step toward a complete, molecularly detailed description of mechanism in the *sui generis* CLC transporters and channels.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                    Designation                                                           Source or\                                                       Identifiers                                                    Additional\
  (species) or\                                                                                                          reference                                                                                                                       information
  resource                                                                                                                                                                                                                                               
  ------------------------------------------------ --------------------------------------------------------------------- ---------------------------------------------------------------- -------------------------------------------------------------- ----------------------------------------------------
  Strain, strain background (*Escherichia coli*)   XL10 Gold                                                             Agilent                                                          200314                                                         Chemically competent cells for DNA propagation

  Recombinant DNA reagent                          pASK-CLC-ec1 (plasmid)                                                PMID:[14718478](https://www.ncbi.nlm.nih.gov/pubmed/14718478)                                                                   Plasmid containing CLC-ec1

  Chemical compound, drug                          n-Decyl-β-D-maltoside                                                 Anatrace                                                         D322                                                           High-purity detergent for protein purification

  Chemical compound, drug                          Lauryl Maltose Neopentyl Glycol (LMNG)                                Anatrace                                                         NG310                                                          High-purity detergent for protein purification

  Chemical compound, drug                          *E. coli* polar lipid extract                                         Avanti Polar lipids                                              100600C                                                        Lipids for protein reconstitution

  Chemical compound, drug                          Isethionic acid                                                       Wako Chemicals                                                   350--15765                                                     Acid form of isethionate, used in transport assays

  Chemical compound, drug                          1-Oxyl-2,2,5,5,-tetramethylpyrroline-3-methyl methanethio-sulfonate   Fisher Scientific                                                NC9859662                                                      Spin label for DEER spectroscopy

  Sequence-based reagent                           forward sequencing primer, pASK/CLC-ec1                               IDT                                                                                                                             5'-CCACTCCCTATCAGTG-3'

  Sequence-based reagent                           forward sequencing primer, CLC-ec1 internal                           IDT                                                                                                                             5'-GGTGTCATTATGTCGACCATTATGTACCGG-3'

  Software algorithm                               XDS                                                                   PMID:[20124692](https://www.ncbi.nlm.nih.gov/pubmed/20124692)    RRID:[SCR_015652](https://scicrunch.org/resolver/SCR_015652)   Data Processing

  Software algorithm                               AIMLESS                                                               PMID:[16369096](https://www.ncbi.nlm.nih.gov/pubmed/16369096)    RRID:[SCR_015747](https://scicrunch.org/resolver/SCR_015747)   Data Processing

  Software algorithm                               PHASER                                                                PMID:[19461840](https://www.ncbi.nlm.nih.gov/pubmed/19461840)    RRID:[SCR_014219](https://scicrunch.org/resolver/SCR_014219)   Structure determination

  Software algorithm                               Coot                                                                  PMID:[20383002](https://www.ncbi.nlm.nih.gov/pubmed/20383002)    RRID:[SCR_014222](https://scicrunch.org/resolver/SCR_014222)   Structure refinement

  Software algorithm                               REFMAC                                                                PMID:[15299926](https://www.ncbi.nlm.nih.gov/pubmed/15299926)    RRID:[SCR_014225](https://scicrunch.org/resolver/SCR_014225)   Structure refinement

  Software algorithm                               HOLE                                                                  PMID:[9195488](https://www.ncbi.nlm.nih.gov/pubmed/9195488)                                                                     Structure analysis

  Software algorithm                               Caver                                                                 PMID:[23093919](https://www.ncbi.nlm.nih.gov/pubmed/23093919)                                                                   Structure analysis

  Software algorithm                               Pymol                                                                 Pymol                                                            RRID:[SCR_000305](https://scicrunch.org/resolver/SCR_000305)   Structure analysis

  Software algorithm                               Adobe Illustrator                                                     Adobe                                                            RRID:[SCR_010279](https://scicrunch.org/resolver/SCR_010279)   Figure generation

  Software algorithm                               Microcal Origin                                                       Microcal                                                         RRID:[SCR_002815](https://scicrunch.org/resolver/SCR_002815)   ITC measurements

  Software algorithm                               pClamp 9.0                                                            Molecular Devices                                                RRID:[SCR_011323](https://scicrunch.org/resolver/SCR_011323)   Transport assays

  Software algorithm                               Igor Pro                                                              Wavemetrics                                                      RRID:[SCR_000325](https://scicrunch.org/resolver/SCR_000325)   Transport assays, difference distance matrices

  Software algorithm                               Matlab                                                                Mathworks                                                        RRID:[SCR_001622](https://scicrunch.org/resolver/SCR_001622)   DEER analysis

  Software algorithm                               PROPKA                                                                PMID:[26596171](https://www.ncbi.nlm.nih.gov/pubmed/26596171)\                                                                  MD simulations
                                                                                                                         PMID:[21269479](https://www.ncbi.nlm.nih.gov/pubmed/21269479)                                                                   

  Software algorithm                               VMD                                                                   PMID:[8744570](https://www.ncbi.nlm.nih.gov/pubmed/8744570)      RRID:[SCR_001820](https://scicrunch.org/resolver/SCR_001820)   MD simulations

  Software algorithm                               DOWSER                                                                PMID:[9162944](https://www.ncbi.nlm.nih.gov/pubmed/9162944)\                                                                    MD simulations
                                                                                                                         PMID:[25328496](https://www.ncbi.nlm.nih.gov/pubmed/25328496)                                                                   

  Software algorithm                               CHARMM-GUI Membrane Builder                                           PMID:[25130509](https://www.ncbi.nlm.nih.gov/pubmed/25130509)                                                                   MD simulations

  Software algorithm                               NAMD2.12                                                              PMID:[16222654](https://www.ncbi.nlm.nih.gov/pubmed/16222654)                                                                   MD simulations
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Protein preparation and purification {#s4-1}
------------------------------------

Mutations were inserted in the WT CLC-ec1 protein using Agilent QuikChange Lightning kit and were confirmed by sequencing. Protein purification was carried out as described ([@bib100]), with a few changes depending on the type of experiment. For ITC experiments, QQQ or E148Q were purified in buffer A (150 mM Na-isethionate, 10 mM HEPES, 5 mM anagrade decyl maltoside (DM) at pH 7.5). For crystallization experiments, QQQ was extracted with DM. The detergent was gradually exchanged for lauryl maltose neopentyl glycol (LMNG) during the cobalt-affinity chromatography step. The final size-exclusion chromatography step was performed in a buffer containing LMNG. All detergents were purchased from Anatrace (Maumee, OH). For DEER spectroscopy experiments, cysteine mutations were made on a WT or QQQ cysteine-less background (C85A/C302A/C347S) ([@bib74]). Proteins were purified under reducing conditions and then labeled with the spin label MTSSL (1-Oxyl-2,2,5,5,-tetramethylpyrroline-3-methyl methanethio-sulfonate) as described ([@bib46]).

Crystallography {#s4-2}
---------------

Purified QQQ protein was concentrated to at least 30 mg/mL. Concentrated protein was mixed with 1.5 parts (w/w) of monolein containing 10% (w/w) cholesterol using the syringe reconstitution method ([@bib10]), to generate a lipidic cubic phase mixture. 25 nL droplets of the mixture were dispensed on glass plates and overlaid with 600 nL of precipitant using a Gryphon crystallization robot (Art Robbins Instruments, Sunnyvale, CA). Crystallization trials were performed in 96-well glass sandwich plates incubated at 16°C. The best crystals were obtained using a precipitant solution consisting of 100 mM Tris (pH 8.5), 100 mM sodium malonate, 30% PEG 400% and 2.5% MPD Crystals were harvested after 3--4 weeks of incubation and flash-frozen in liquid nitrogen without further additives. Figures were prepared using PyMOL and Adobe Illustrator.

Structure determination and refinement {#s4-3}
--------------------------------------

X-ray diffraction data were collected at APS at GM/CA beamline 23ID-D and were processed using XDS ([@bib44]) and AIMLESS ([@bib22]) from the CCP4 suite ([@bib103]). Owing to radiation damage, a complete dataset was collected by merging data from three different crystals. Phases were obtained using PHASER ([@bib66]) with PDB ID 1ots as a search model. Iterative refinement was performed manually in Coot ([@bib19]) and REFMAC ([@bib73]). The final model contained all residues except those of Helix A due to lack of density for this region of the protein. Helix A is observed in different conformations in the monomeric versus dimeric CLC-ec1 structures, and has no impact on function ([@bib88]).

Reconstitution and flux assays {#s4-4}
------------------------------

Flux assay results presented in this paper required a variety of experimental conditions for reconstitutions and flux assays, summarized in [Table 2](#table2){ref-type="table"}. For flux assays comparing activity at pH 7.5 and 4.5, purified CLC-ec1 were first reconstituted at pH 6. The samples were then aliquoted and pH-adjusted using a 9:1 ratio of sample and the adjustment buffer. This step was taken to eliminate variability from separate reconstitutions. For experiments testing H^+^ pumping in mutants, a pH gradient was used to ensure any measured H^+^ transport was from H^+^ pumping and not H^+^ leak.

###### Buffers used for Reconstitution and Flux Assays.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Buffer R                                                                                                                         Buffer F                                                                        Ion flux monitored   Protein-lipid\   Protein per\
                                                                                                                                                                                                                                        ratio (µg/mg)    assay (µg)
  -------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- -------------------- ---------------- --------------
  Comparing turnover rates at pH 7.5 and 4.5 ([Figure 4](#fig4){ref-type="fig"})                                                                                                                                                                         

  333 mM KCl, 55 mM Na-citrate, 55 mM Na~2~HPO~4~, pH 6.0\                                                                         333 mM K-isethionate, 55 µM KCl, 55 mM Na-citrate, 55 mM Na~2~HPO~4~, pH 6.0\   Cl^--^               0.4--0.8         0.4--0.8
  pH adjustments by adjustment buffers (10x) (after reconstitution):\                                                              pH adjustments by adjustment buffers (10x):\                                                                          
  • 0.16 M citric acid, 0.42 M Na~3~PO~4~ (for pH 7.5)\                                                                            • 0.16 M citric acid, 0.42 M Na~3~PO~4~ (for pH 7.5)\                                                                 
  • 0.43 M citric acid, 0.29 M Na~3~PO~4~ (for pH 4.5)                                                                             • 0.43 M citric acid, 0.29 M Na~3~PO~4~ (for pH 4.5)                                                                  

  Testing H^+^ pumping of mutants ([Figure 9](#fig9){ref-type="fig"}; [Figure 9---figure supplement 1](#fig9s1){ref-type="fig"})                                                                                                                         

  300 mM KCl, 40 mM Na-citrate, pH 4.0                                                                                             300 mM K-isethionate, 50 µM KCl, 2 mM Na-citrate, pH 4.3                        H^+^ and Cl^--^      0.4--5.0         0.4--10

  Testing DEER samples ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"})                                                                                                                                                                       

  300 mM KCl, 40 mM Na-citrate, pH 4.5                                                                                             300 mM K-isethionate, 50 µM KCl, 2 mM Na-citrate, pH 4.5                        Cl^--^               0.4              0.4--0.5
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To measure the rate of H^+^ and Cl^--^ transport in flux assays, purified CLC-ec1 proteins were reconstituted into phospholipid vesicles ([@bib100]). *E coli* polar lipids (Avanti Polar Lipids, Alabaster, AL) in chloroform were dried under argon in a round-bottomed flask. To ensure complete removal of chloroform, the lipids were subsequently dissolved in pentane and dried under vacuum on a rotator, followed by further drying (5 min) under argon. The lipids were then solubilized at 20 mg/mL in buffer R ([Table 2](#table2){ref-type="table"}) with 35 mM CHAPS on the rotator for 1.5--2 hr. Purified protein (0.4--5 µg per mg lipids) samples or control buffer solution were then added to the prepared lipid-detergent mix and incubated for 10--20 min. Each protein or control reconstitution was divided into 2--4 samples for dialysis to remove detergent, with three buffer changes over 36--60 hr. Following dialysis, each sample was divided into 2--4 for replicate measurements. For experiments shown in [Figures 4](#fig4){ref-type="fig"} and [9](#fig9){ref-type="fig"}, the replicate measurements were averaged to obtain a turnover rate value, and each of these averages was counted as one 'n'. For experiments shown in [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} (DEER samples), the replicate measurements from each sample are shown separately.

Reconstituted vesicles were subjected to four freeze-thaw cycles and were then extruded with an Avanti Mini Extruder using a 0.4 µm-filter (GE Healthcare, Chicago, IL) 15 times. For each assay, 60--120 µL of extruded sample were buffer-exchanged through 1.5- to 3.0 mL Sephadex G-50 Fine resin (GE Healthcare, Chicago, IL) columns equilibrated with buffer F ([Table 2](#table2){ref-type="table"}). Exchange was accomplished by spinning the columns at \~1100 g for 90 s using a clinical centrifuge. The collected sample (80--200 µL) was then added to buffer F (500--600 µL) for flux-assay measurement. Extravesicular \[Cl^--^\] and \[H^+^\] were monitored using a Ag·AgCl electrode and a pH electrode, respectively. The electrodes were calibrated by known additions of KCl (in 20--136 nmol steps) and NaOH (in 10--50 nmol steps). Sustained ion transport by CLC-ec1 was initiated by addition of 1.7--3.4 µg/mL of valinomycin (from 0.5 mg/mL stock solution in ethanol). At the end of each transport experiment, detergent was added to release all Cl^--^ from the vesicles. This step served as a quality check to confirm that a reasonable yield of vesicles was obtained following the spin-column step. Samples that exhibited a total Cl^--^ release (sum of Cl^--^ released by transport and detergent release)\>30% than the average were excluded. Using this criterion, 3 out of the 210 assays performed as part of this study were excluded.

Isothermal titration calorimetry {#s4-5}
--------------------------------

Titration isotherms were obtained using a VP-ITC microcalorimeter (MicroCal LLC, Northampton, MA) at 25°C. For the experiment, QQQ or E148Q protein samples were purified in buffer A. Titrant used in the experiment was 30 mM KCl in buffer A. The starting concentration of protein was 15--20 µM, in a volume of 1.5 mL. KCl (30 mM) was syringe-titrated into the sample cell in thirty 10 µL injections. The reference data were obtained by titrating buffer A into the protein-containing solution. Data were analyzed using Origin 7.0 software, with fitting using the 'one set of sites' model (keeping n = 1). The other thermodynamic parameters were obtained accordingly. Isethionate was chosen as the anion of choice for purification of proteins for the ITC experiments since the QQQ mutant shows aggregation upon purification in tartrate-containing solutions, which were previously used for ITC experiments with WT and mutant variants of CLC-ec1 ([@bib84]; [@bib46]). The mutant is comparatively stable in isethionate and continues to remain stable throughout the ITC experiment. [Figure 4A](#fig4){ref-type="fig"} shows the gel filtration chromatograms of the mutants before and after the ITC experiments.

DEER spectroscopy {#s4-6}
-----------------

CW-spectra were collected on a Bruker EMX at 10 mW power with a modulation amplitude of 1.6G. Determination of the spin concentration of the samples were obtained using Bruker's built-in Spin Quantitation method. The spin concentration is divided by the protein concentration to obtain the labeling efficiency. DEER experiments were performed at 83 K on a Bruker 580 pulsed EPR spectrometer at Q-band frequency (33.5 GHz) using either a standard four-pulse protocol ([@bib41]) or a five-pulse protocol ([@bib8]). Analysis of the DEER data to determine P(r) distance distributions was carried out in homemade software running in MATLAB ([@bib9]; [@bib94]). In the original five-pulse protocol paper the pure five-pulse signal was obtained by subtracting the artefact four-pulse data ([@bib8]). This method requires the ability to discern clearly the extent of the artefact. For the data in this study, we chose to simultaneously fit the four- and five-pulse data with a single Gaussian component in order to improve accuracy of subtracting the four-pulse artefact ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). Confidence bands for the distance distributions were determined using the delta method ([@bib36]). The confidence bands define the 95% confidence interval that the best fit distance distribution will have. In the case of a Gaussian distribution, the shape of the confidence bands can be non-Gaussian.

Simulation system setup {#s4-7}
-----------------------

The structure of the CLC-ec1 QQQ mutant crystallized in this work at 2.6 Å resolution was used as the starting structure for the MD simulation. The 2 Cl^--^ ions bound at S~cen~ and S~int~ sites in each of the two subunits were preserved for the simulation. In our initial refinement of the QQQ structure, we had modeled water rather than Cl^--^ at the S~ext~ site, and therefore the simulation was performed without Cl^--^ at this site. The pKa of each ionizable residue was estimated using PROPKA ([@bib77]; [@bib89]), and the protonation states were assigned based on the pKa analysis at pH 4.5. Specifically, E111, E202, E235, and E414 were protonated in the simulation. All other side chains are in their default protonation state. Missing hydrogen atoms were added using PSFGEN in VMD ([@bib35]). In addition to the crystallographically resolved water molecules, internal water molecules were placed in energetically favorable positions within the protein using DOWSER ([@bib108]; [@bib72]), including in a bridging position between Gln~ex~ and Gln~in~. This water was not present in our initial structural model but was subsequently added based on experimental density ([Figure 6E,F](#fig6){ref-type="fig"}). The QQQ protein was embedded in a POPE lipid bilayer using the CHARMM-GUI Membrane Builder ([@bib105]). The membrane/protein system was fully solvated with TIP3P water ([@bib43]) and buffered in 150 mM NaCl to keep the system neutral. The resulting systems consisting of \~155,000 atoms were contained in a 164 × 127×98 Å^3^ simulation box.

Simulation protocols {#s4-8}
--------------------

MD simulation was carried out with NAMD2.12 ([@bib82]) using CHARMM36 force field ([@bib47]; [@bib34]) and a time step of 2 fs. Periodic boundary conditions were used throughout the simulations. To evaluate long-range electrostatic interactions without truncation, the particle mesh Ewald method ([@bib13]) was used. A smoothing function was employed for short-range nonbonded van der Waals forces starting at a distance of 10 Å with a cutoff of 12 Å. Bonded interactions and short-range nonbonded interactions were calculated every two fs. Pairs of atoms whose interactions were evaluated were updated every 20 fs. A cutoff (13.5 Å) slightly longer than the nonbonded cutoff was applied to search for interacting atom pairs. Simulation systems were subjected to Langevin dynamics and the Nosé--Hoover Langevin piston method ([@bib76]; [@bib32]) to maintain constant pressure (p=1 atm) and temperature (T = 310 K) (NPT ensemble).

The simulation system was energy-minimized for 10,000 steps, followed by two stages of 1-ns relaxation. Both the protein and the Cl^--^ ions in the binding sites were positionally restrained (k = 1 kcal⋅mol^−1^⋅Å^−2^) in the first 1-ns simulation to allow the membrane to relax. In the second 1-ns simulation, only the protein backbone and the bound Cl^--^ ions were positionally restrained (k = 1 kcal⋅mol^−1^⋅Å^−2^) to allow the protein side chains to relax. Then a 600-ns equilibrium simulation was performed for the system without any restraint applied.

Analysis of water pathways {#s4-9}
--------------------------

The water pathways between Q148 (Gln~ex~) and the intracellular bulk water was searched using a breadth-first algorithm. In Subunit 2 of the homodimer, Gln~ex~ drifted up and away from the 'out' position at the beginning of the simulation (within five ns), and it did not return to the 'out' position during the simulation. In Subunit 1, Gln~ex~ remained near the 'out' position for the first 400 ns; we focused our analysis of water pathways on this subunit. A distance-based criterion of 2.5 Å for the hydrogen bonds, which was found to be useful and inexpensive in computational terms in a previous study ([@bib62]) was used to determine whether water molecules are connected through continuous hydrogen-bonded network. The water pathway with the smallest number of O-H bonds in each frame was considered as the shortest hydrogen-bonded path. The first water molecule in each water pathway is searched using a distance cutoff of 3.5 Å for any water oxygen atoms near the OE1/NE2 atoms of Q148. The water pathway is considered to reach the intracellular bulk once the oxygen atom of the newly found water molecules is at z \< −15 Å (membrane center is at z = 0).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The manuscript presents a description and functional assessment of a new structure of the CLC-ec1 chloride/proton exchanger that represents a conformation that mimics the protonated state of three important glutamate residues. A series of complementary experimental and theoretical approaches paint an extended picture of the transport cycle and the new structure fills some of the predicted conformations as well as presents unexpected results. The authors have extensively revised their manuscript and improved the presentation with a better description and interpretation of results as well as a few new experiments. This is a fine contribution that increases our understanding of these remarkable transporters.

**Decision letter after peer review:**

Thank you for submitting your article \"Structural characterization of an intermediate reveals a unified mechanism for the CLC Cl^-^/H + transport cycle\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Leon D Islas as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Richard Aldrich as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

In consultation, the reviewers agreed that the new structure represents a significant advance, but they also concluded that at this stage the structure, calculations and experiments do not support a unified mechanism of transport for CLC transporters. The reviewers request that the paper should focus only on characterization of the global structural changes observed and that the conclusion of a unified global transport mechanism be toned down. This also means that the title of the paper should be changed accordingly. Perhaps the paper can be a short communication instead of a full article.

Summary:

CLC chloride/proton exchangers are important physiological mediators of chloride movement. Several structures have been determined ant these, together with functional studies have painted a picture of the transport cycle. However, some parts of the cycle are lacking and he precise role of protonation/deprotonation of key acidic residues in not fully understood.

In this manuscript Chavan et al. report on a new structure of a mutant of the CLC-ec1 transporter. The structural data is also accompanied by spectroscopic (DEER) measurements of conformational changes induced by pH and chloride transport essays.

The authors show that the triple QQQ mutant might represent a new intermediate state, presumably corresponding to protonated external and internal glutamate residues. This structure additionally shows an enlarged entry pathway for extracellular chloride. Interestingly, DEER experiments show that in WT CLC, low pH induces a conformational change compatible with the QQQ structure.

Essential revisions:

While the new structure is novel and interesting, it is unclear that the additional experiments and simulations pin down this newly proposed mechanism. For instance, while the QQQ construct may have increased water access, it does not move protons, and is in fact in a similar conformation to that found in the CLC-1 channel structure. It seems possible that the water access could pertain to uncoupled transport, or channel-like permeation, rather than a means of efficiently transferring the proton to/from Glu~ex~. Furthermore, the significant observation in this structure is the fact that the two ionizable GLUs are now 5.6 Å; away from one another -- a point that appears to become irrelevant in the water accessibility mechanism. Therefore, the presentation of this new mechanism needs to be carefully considered. The following outlines some of the specific questions associated with this study:

1\) It is unclear that the QQQ structure represents the protonated structure that pertains to the coupled transport in WT CLC-ec1. While experiments were carried out to show that proton pumping does not require ionization at E203, it still may be required for coupled and efficient transport. A previous study (Lim et al.) showed that three non-ionizable E203 mutants -- G, S and Q -- show low, near-baseline proton uptake that they considered to be inactive. They interpreted this as weak pumping due to \"direct, inefficient proton donation from solvent hydronium ion\". This seems to also explain the functional results shown here, with weakly coupled 20:1 Cl^-^/H^+^ transport. Furthermore, the MD simulations of the QQQ construct appear to support this, with a mechanism of increased water access allowing for uncoupled proton transfer directly to the external glutamate. Finally, the \"out\" conformation of Glu~ex~ is also observed in the channel structure CLC-1, which exhibits uncoupled Cl^-^ transport. Therefore, it is not clear whether the observations from uncoupled transport examples pertain to the tightly coupled transport mechanism in the wild-type transporter.

2\) The results from the DEER measurements appear to be qualitative. The data from position 374 and 385 do not appear to agree with the expected distances from the crystal structures. Furthermore, the changes observed are much larger than the expected 2 A; changes. It raises the question of whether the protein is much more dynamic at low pH, and whether it is even possible to correlate the change in distributions to the expected changes in distance. It would be useful to analyze other positions, where no change is expected, for comparison.

3\) It appears as though there are many changes in the protein structure, as depicted in the backbone RMSD analysis in Figure 3C. This is very interesting, because it has not been observed in any other CLC structure. Do the helices move independently, or does the inverted topology repeat move as rigid bodies? So far, only limited analysis of the structure has been presented. It would be useful to elaborate on this analysis, including adding a figure overlaying the two structures, showing all of the changes in the protein.

4\) \"within kissing distance\" implies the sidechains are near contact. However, a 5.6 Å; measured distance means that these chemical groups are significantly separated. The description is misleading as it suggests that there is the possibility of the residues handing the proton off to one another. It is more likely that there would have to be a water coordinated between (as is observed in the MD simulation), or further conformational change required to bring these residues closer. This should be clarified throughout the manuscript, especially in the cartoons where it shows the two residues in contact.

5\) What are the protonated states used in the MD simulations? This is not stated explicitly but is important for future reproducibility of the simulations.

6\) Please provide trajectories, or snapshot PDB files of the final equilibrated configurations.

7\) This is a high resolution structure for CLC-ec1. Are there crystallographic waters resolved inside the core of the protein? Or along the pathway? Some analysis of this would be useful to the field.

8\) Water wires are mentioned throughout the analysis, however, the snapshots and simulation look like the water is disordered. Can you provide analysis on specific water wire geometries?

9\) Subsection "A unifying model for the CLC transport mechanism", third paragraph -- you state that the change in the N helix results in changes in ion coordination that are predicted to decrease affinity of this site. However, the ITC measurements argue against this, since the QQQ construct has a higher affinity. Can you clarify this confusion?

10\) The fact that the QQQ mutant represents a stable \"native\" conformation intermediate that can be captured in a X-ray crystal structure and mimics the H^+^-loaded state of the transporter strongly suggests that it would be possible to obtain the structure of the WT (or E148A) at low pH. This would be much more directly relevant for the conclusions of the authors than the results on a triple mutant.

Please add in the manuscript whether the attempt to crystallize the WT or E148A at low pH has been made and why it did not work.

11\) A major difference of this structure compared to previous ones is the larger access to the permeation pathway on the extracellular side with removal of all the constrictions present in the WT and the E148A mutant. However, transport rate is only 2 times faster whereas one would expect a much larger functional effect. The data on the Cl^-^ K~d~ for E148A and QQQ are presented in Figure 3---figure supplement 2 where it is also explained that it was not possible to use Br- to distinguish the binding affinities at different sites. The K~d~s for the 2 mutants are very similar.

More importantly, the K~d~ reported for E148A and the QQQ mutants are very similar. How can this be reconciled with a larger permeation pathway in the QQQ mutant but only a doubling of the transport rate? This casts some question marks on the extent to which the QQQ structure is representative of a native conformation intermediate.

The inconsistency between the similar K~d~ and the doubling of the transport rate (in spite of a larger pore) between E148A and the QQQ mutant should be more clearly acknowledged and on this basis the speculative nature of the conclusions is explicitly stated.

12\) In a previous study, Accardi et al. (JGP 2004) reported that the E203A mutation abolished proton transport in CLC-ec1. In the present manuscript the authors state that the double mutant E113A/E203A is able to transport protons. It should be clarified in the manuscript whether this difference is a result of the E113A mutation or if the result contrasts with the ones of Accardi et al. In this case the authors should indicate in the Discussion possible reasons for the discrepancy.

13\) Is it possible that some of the residues observed to change conformation in the QQQ mutant of CLC-ec1 (for example in Helix P and N) are involved, when mutated, in genetic diseases when expressed in human CLC transporters? Could this be a way to establish the relevance of the conclusions on CLC-ec1 for the entire class of CLC proteins?

10.7554/eLife.53479.sa2

Author response

We revised the manuscript to address the concerns, including addition of new data to support the QQQ structural model as well as revisions to the text to clarify what has been learned from our experimental and computational results and what aspects of our proposed model require additional (future) testing. We respectfully assert that our manuscript represents a substantive (even pivotal) contribution to the literature and warrants publication as a regular research article. The bulk of the reviewer criticisms reflect uncertainty as to whether the structure represents an on-pathway conformation. We shared this uncertainty, but we consider that the multiple lines of evidence presented here argue strongly for the mechanistic relevance -- indeed the central mechanistic relevance -- of the structure. We endeavor to support our view in the detailed responses below.

> Essential revisions:
>
> 1\) It is unclear that the QQQ structure represents the protonated structure that pertains to the coupled transport in WT CLC-ec1. While experiments were carried out to show that proton pumping does not require ionization at E203, it still may be required for coupled and efficient transport. A previous study (Lim et al.) showed that three non-ionizable E203 mutants -- G, S and Q -- show low, near-baseline proton uptake that they considered to be inactive. They interpreted this as weak pumping due to \" direct, inefficient proton donation from solvent hydronium ion\". This seems to also explain the functional results shown here, with weakly coupled 20:1 Cl^-^/H^+^ transport. Furthermore, the MD simulations of the QQQ construct appear to support this, with a mechanism of increased water access allowing for uncoupled proton transfer directly to the external glutamate. Finally, the \"out\" conformation of Glu~ex~ is also observed in the channel structure CLC-1, which exhibits uncoupled Cl^-^ transport. Therefore, it is not clear whether the observations from uncoupled transport examples pertain to the tightly coupled transport mechanism in the wild-type transporter.

We have revised the text extensively to clarify the points raised in this paragraph.

Further support for the QQQ mutant representing a WT CLC-ec1 conformation. To provide further support for our interpretation that the QQQ represents an intermediate in the transport cycle, we performed additional DEER/EPR experiments to compare the protein conformation of QQQ with WT. Using spin labels on Helices N, O, P, and G, we shown that the QQQ conformation is similar to that adopted by WT at pH 4.5 (Figure 7).

Coupling does not require ionization at E203. We have clarified that our results are definitive in demonstrating that E203 protonation is not required for coupled transport. Lim and Miller, 2009, indeed previously showed that three non-ionizable E203 mutants exhibited low, near-baseline activity. However, they were very explicit in their waffling regarding the interpretation these results. They pointed out that the small signals *might* be due to pumping (coupling) but that they could just as well be assay artifacts. Had they been convinced that their data demonstrated coupling (even weakened 20:1 coupling), they would have concluded at that time that a titratable group at E203 is *not* required for the fundamental coupling mechanism. We note that the H^+^ turnover rates reported in that research article are not unitary turnover rates, and therefore coupling ratios cannot be derived from those measurements. A major strength of our current work is that -- motivated by the QQQ structure -- we re-examined this question and demonstrated definitively that proton pumping (coupling) does not require titration of E203. Please also see our response to point 12. We have improved our discussion of these points in the manuscript (subsection "Proton pumping without a titratable residue at the Glu~in~ position", Discussion, third and fifth paragraphs).

Uncoupled proton transfer.Our observation of water access to the external glutamate from the intracellular side is agnostic as to whether it is part of a coupled or uncoupled H^+^ transport process. It is, however, an observation that fits exceedingly well into a model for coupled H^+^ transport, one that is consistent with all experimental results on coupled transport. We note that experimentally we do not observe uncoupled proton transport in the QQQ mutant, nor has anyone reported uncoupled H^+^ transport in any CLC mutant.

The "out" conformation is observed in the CLC-1 channel structure. We note that Park and MacKinnon's rationale for concluding that the "out" position may be unique to the channels was based on the observation that in previously known CLC transporters the "out" conformation would generate steric clashes, and not on any argument that an "out" conformation necessarily precludes an antiport mechanism. We have added text to the manuscript to explain this point and the point that CLC channel and transporter mechanisms are highly related, and therefore that it is completely reasonable for the two to share many similar mechanistic steps, including the same "out" conformation for Glu~ex~. We have included this point in the manuscript (subsection "New conformation of Glu~ex~" and Discussion, fourth paragraph).

While it is generally accepted that CLC channels are "broken" (uncoupled) transporters, the mechanistic details of which steps are "broken" in the channel uncoupling are not yet established. One possibility that has been suggested is that the inner and outer Cl^--^ gates are no longer opened and closed in a coupled manner. This possibility is supported by the observation that the structures of CLC channels (CLC-1 and CLC-K) show intracellular gates in open-appearing conformations. In the revised manuscript, we have added text and a figure illustrating the fact that the QQQ mutant retains a constricted intracellular gate (subsection "The intracellular barrier remains constricted" and Figure 3), thus supporting its feasibility as representing an intermediate in a coupled transport cycle.

> 2\) The results from the DEER measurements appear to be qualitative. The data from position 374 and 385 do not appear to agree with the expected distances from the crystal structures. Furthermore, the changes observed are much larger than the expected 2 A; changes. It raises the question of whether the protein is much more dynamic at low pH, and whether it is even possible to correlate the change in distributions to the expected changes in distance. It would be useful to analyze other positions, where no change is expected, for comparison.

The DEER measurements are quantitative, not qualitative, and it is possible to relate changes in the crystal structures to changes in the distance distributions (Kazmier et al. (2014) Proc Natl Acad Sci U S A. 111(41):14752-7. doi: 10.1073/pnas.1410431111). As to the absolute magnitude of the changes in the crystal structures and distance distributions, there is not absolute correlation as there is some uncertainty introduced by the potential rotameric state of the spin-label. We have carried out two different modeling methods, MMM and MDDS (Polyhach et al. (2011) Phys Chem Phys. 13(6):2356-66. doi: 10.1039/c0cp01865a; Islam et al. (2013) J Phys Chem B. 117(17):4740-54. doi: 10.1021/jp311723a), that place spin-labeled rotamers on a fixed protein backbone to derive an expected distance distribution ([Author response image 1](#respfig1){ref-type="fig"}). While neither method perfectly matches the width of the distance distribution, as expected (Alexander et al. (2013) PLoS One. 8(9):e72851. doi: 10.1371/journal.pone.0072851), they support that the changes seen in the DEER data are reflective of the changes in the crystal structure.

To further support the relevance of the DEER measurements, we evaluated an additional position, on the intracellular side, to complement the previous measurements at sites at the extracellular side. Moreover, we added DEER data for spin-labeled QQQ CLC-ec1 at the 5 positions reported for WT. These new data are shown in Figure 7.

![Modeling results for expected distance distributions using MMM (left panels) or MDDS (right panels).\
While neither method perfectly matches the width of the distance distribution, as expected (Alexander et al. (2013) PLoS One. 8(9):e72851), they support that the changes seen in the DEER data are reflective of the changes in the crystal structure.](elife-53479-resp-fig1){#respfig1}

> 3\) It appears as though there are many changes in the protein structure, as depicted in the backbone RMSD analysis in Figure 3C. This is very interesting, because it has not been observed in any other CLC structure. Do the helices move independently, or does the inverted topology repeat move as rigid bodies? So far, only limited analysis of the structure has been presented. It would be useful to elaborate on this analysis, including adding a figure overlaying the two structures, showing all of the changes in the protein.

Thank you for this suggestion. We have included additional descriptions of the structural changes in the main text (subsection "Overall conformational change in QQQ") along with new figures (Figure 5C, D; Figure 5---figure supplement 3; Figure 6).

> 4\) \"within kissing distance\" implies the sidechains are near contact. However, a 5.6 Å; measured distance means that these chemical groups are significantly separated. The description is misleading as it suggests that there is the possibility of the residues handing the proton off to one another. It is more likely that there would have to be a water coordinated between (as is observed in the MD simulation), or further conformational change required to bring these residues closer. This should be clarified throughout the manuscript, especially in the cartoons where it shows the two residues in contact.

We have revised the cartoons and removed the "within kissing distance" phrase. To make the narrative easier to follow, we have separated the introduction and discussion of the changes at Glu~ex~ and Glu~in~. Glu~ex~ changes are introduced and discussed in Figure 1 and following; Glu~in~ changes are introduced and discussed in Figure 6and following.

> 5\) What are the protonated states used in the MD simulations? This is not stated explicitly, but is important for future reproducibility of the simulations.

The simulation was performed using the QQQ mutant structure as the template, with three glutamates mutated to glutamine (E148Q, E203Q, E113Q), and therefore there is no concern regarding their protonation states. Regarding the other protonatable residues: since the triple mutant represents the CLC-ec1 structure under low pH, we assigned the protonation state of each titratable residue in the protein based on the pKa analysis at pH 4.5 using PROPKA. To be specific, the following amino acids were in their protonated states in the simulation: E111, E202, E235, and E414. All other side chains are in their default protonation state. We have added this information to the Materials and methods subsection "Reconstitution and chloride flux assay", first paragraph.

> 6\) Please provide trajectories, or snapshot PDB files of the final equilibrated configurations.

Representative snapshot PDB files are provided in Figure 8---source data 1. The 5 snapshot PDBs in this zip file represent the 5 different water pathways observed in our simulations (Figure 8---figure supplement 1).

> 7\) This is a high resolution structure for CLC-ec1. Are there crystallographic waters resolved inside the core of the protein? Or along the pathway? Some analysis of this would be useful to the field.

Good point. We have added this information in Figure 6---figure supplement 1.

> 8\) Water wires are mentioned throughout the analysis, however, the snapshots and simulation look like the water is disordered. Can you provide analysis on specific water wire geometries?

The water molecules are not disordered, although from the figure it may appear so. In fact, we have characterized these water wires after careful analysis of the water arrangements ensuring that the water molecules are connected and form a H-bonded configuration required for proton transport. We have included the definition of water pathways in "Analysis of water pathways" in "Materials and methods". The pathways are defined only when there are water molecules connected through a continuous hydrogen-bonded network. The reason that in the figure the water pathway might appear a bit disordered may be due to inclusion of all water molecules in the protein cavity, rather than only the ones that form a single file. We opted to include all water molecules (rather than just showing those forming a single file pathway) to highlight how much the protein interior was hydrated during the simulation. The pdb files we have provided (see response to point \#6) allow the reader to examine the pathways closely.

> 9\) Subsection "A unifying model for the CLC transport mechanism", third paragraph -- you state that the change in the N helix results in changes in ion coordination that are predicted to decrease affinity of this site. However, the ITC measurements argue against this, since the QQQ construct has a higher affinity. Can you clarify this confusion?

It is correct that, based on the changes observed at Helix N, we anticipated that the affinity of the QQQ construct for Cl^--^ would be decreased compared to E148Q. There are several very reasonable explanations for the observation that QQQ and 148Q have similar affinities measured by ITC. First, the ITC measurement does not distinguish between Cl^--^ binding to the central site (S~cen~), which appears structurally identical in QQQ and E148Q, and the external site (S~ext~), which exhibits some structural differences. Second, the crystal structures are static snapshots of the proteins, whereas the ITC measurements are performed on protein in detergent solution. Conformational flexibility in solution may allow the S~ext~ binding site in QQQ to make small (\~0.5 Å) adjustments that generate an increased binding affinity. We have completely rewritten this section and the section on QQQ and E148Q transport assays (subsection "Comparison of QQQ and E148Q Cl^--^ binding and transport rates") to clarify the point that even though these mutants display identical Cl^--^ binding affinities (a thermodynamic measurement), they display different Cl^--^ transport rates (a kinetic measurement) and that our results are completely consistent with our interpretation that the Helix-N opening occurs as part of the normal transport cycle. Please also see our response to point \#11.

> 10\) The fact that the QQQ mutant represents a stable \"native\" conformation intermediate that can be captured in a X-ray crystal structure and mimics the H^+^-loaded state of the transporter strongly suggests that it would be possible to obtain the structure of the WT (or E148A) at low pH. This would be much more directly relevant for the conclusions of the authors than the results on a triple mutant. Please add in the manuscript whether the attempt to crystallize the WT or E148A at low pH has been made and why it did not work.

We now describe our crystallization attempted on WT CLC-ec1 at low pH, in the first paragraph of the Discussion. The protein is very soluble at low pH, and we did not obtain any crystals even at 50 mg/mL protein. (At pH 8.5, CLC-ec1 crystallizes from solutions at 10-20 mg/mL.)

> 11\) A major difference of this structure compared to previous ones is the larger access to the permeation pathway on the extracellular side with removal of all the constrictions present in the WT and the E148A mutant. However, transport rate is only 2 times faster whereas one would expect a much larger functional effect. The data on the Cl^-^ K~d~ for E148A and QQQ are presented in Figure 3---figure supplement 2 where it is also explained that it was not possible to use Br- to distinguish the binding affinities at different sites. The K~d~s for the 2 mutants are very similar.
>
> More importantly, the K~d~ reported for E148A and the QQQ mutants are very similar. How can this be reconciled with a larger permeation pathway in the QQQ mutant but only a doubling of the transport rate? This casts some question marks on the extent to which the QQQ structure is representative of a native conformation intermediate. The inconsistency between the similar K~d~ and the doubling of the transport rate (in spite of a larger pore) between E148A and the QQQ mutant should be more clearly acknowledged and, on this basis, the speculative nature of the conclusions is explicitly stated.

We thank the reviewers for raising these points, which guided us in making clarifications and improvements in the manuscript, rewriting the section describing these results (subsection "Comparison of QQQ and E148Q Cl^--^ binding and transport rates" and Figure 4). A critical point we had not made clear is that the prediction that Cl^--^ transport through QQQ will be faster than through E148Q is agnostic towards the magnitude of the difference. The wider vestibule in QQQ predicts that transport through QQQ will be faster than through E148Q, if extracellular gate-opening is a rate-limiting step. On the other hand, if Cl^--^ transport through E148Q and QQQ have the same rate-limiting step, then Cl^--^ transport rates should be similar. Experimental measurements revealed that QQQ Cl^--^ transport rates are \~2-fold faster than E148Q transport rates at pH 7.5, the pH at which the binding studies were performed (Figure 4B, C), indicating that the two mutants have different rate-limiting steps. Thus, the prediction is supported. A further prediction is that if this difference in transport rates is due to the wider extracellular Cl^--^ entryway in QQQ compared to E148Q, then lowering the pH (to allow E148Q to adopt the QQQ-like (outward-facing open) conformation) should increase the Cl^--^ transport rate. Consistent with this prediction, transport rates of the E148Q mutant increase by 2-fold at pH 4.5 (Figure 4D). While the transport rates of QQQ and E148Q remain slower than WT CLC-ec1 by \~6-fold, such a result is not surprising (actually, it is expected) given that these Glu~ex~ mutants lack a negatively charged carboxylate to compete Cl^--^ out of the permeation pathway. Thus, these results support the conclusion that E148Q CLC-ec1 (and by extension WT CLC-ec1) undergoes an opening of the extracellular vestibule at low pH. To provide further support that the QQQ structure represents a native conformation intermediate, we additionally added new DEER data comparing QQQ to WT CLC-ec1 (Figure 7).

> 12\) In a previous study, Accardi et al. (JGP 2004) reported that the E203A mutation abolished proton transport in CLC-ec1. In the present manuscript the authors state that the double mutant E113A/E203A is able to transport protons. It should be clarified in the manuscript whether this difference is a result of the E113A mutation or if the result contrasts with the ones of Accardi et al. In this case the authors should indicate in the Discussion possible reasons for the discrepancy.

Thank you for raising the point that we should provide additional information discussion concerning these previous results. We have added new data to the manuscript, reporting flux assay results on single mutants at the Glu~in~ position, E203A and E203Q (Figure 9 and Figure 9---figure supplement 1). We find that both mutants can pump protons. Interestingly, E203A retains stronger coupling stoichiometry than E203Q (10:1 versus 75:1). In the Accardi et al. manuscript (JGP 2005), it is the latter mutant (E203Q) that was examined. There is no discrepancy between our results and those of Accardi et al., whose report of reversal potentials for E203Q (Figure 2C in Accardi et al., 2005) are consistent with a 75:1 coupling stoichiometry. Accardi et al. did not examine the E203A mutant. We have included a discussion of these points in the manuscript, subsection "Proton pumping without a titratable residue at the Glu~in~ position", last paragraph.

> 13\) Is it possible that some of the residues observed to change conformation in the QQQ mutant of CLC-ec1 (for example in Helix P and N) are involved, when mutated, in genetic diseases when expressed in human CLC transporters? Could this be a way to establish the relevance of the conclusions on CLC-ec1 for the entire class of CLC proteins?

Thank you for this suggestion. We have added relevant references to disease-causing mutations (subsections "Opening of the extracellular vestibule" and "Overall conformational change in QQQ"). We have modified the title to "A CLC-ec1 mutant reveals global conformational change and suggests a unifying mechanism for the CLC Cl^--^/H^+^ transport cycle".

[^1]: These authors contributed equally to this work.
